Placebo to match LY, Muvalaplin
J2O-MC-EKBG
Phase 3 small_molecule active
Quick answer
Placebo to match LY, Muvalaplin for Elevated Lp(a), Atherosclerotic Cardiovascular Disease (ASCVD) is a Phase 3 program (small_molecule) at Eli Lilly Co. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Eli Lilly Co.
- Indication
- Elevated Lp(a), Atherosclerotic Cardiovascular Disease (ASCVD)
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active